These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 14643807)
21. A feasibility study of a multimodal stimulation bioreactor for the conditioning of stem cell seeded cardiac patches via electrical impulses and pulsatile perfusion. Herrmann FEM; Lehner A; Koenig F; Hollweck T; Fano C; Dauner M; Eissner G; Hagl C; Akra B Biomed Mater Eng; 2019; 30(1):37-48. PubMed ID: 30530957 [TBL] [Abstract][Full Text] [Related]
23. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Mihic A; Li J; Miyagi Y; Gagliardi M; Li SH; Zu J; Weisel RD; Keller G; Li RK Biomaterials; 2014 Mar; 35(9):2798-808. PubMed ID: 24424206 [TBL] [Abstract][Full Text] [Related]
24. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Sekine H; Shimizu T; Hobo K; Sekiya S; Yang J; Yamato M; Kurosawa H; Kobayashi E; Okano T Circulation; 2008 Sep; 118(14 Suppl):S145-52. PubMed ID: 18824746 [TBL] [Abstract][Full Text] [Related]
25. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. Kofidis T; de Bruin JL; Hoyt G; Lebl DR; Tanaka M; Yamane T; Chang CP; Robbins RC J Thorac Cardiovasc Surg; 2004 Oct; 128(4):571-8. PubMed ID: 15457158 [TBL] [Abstract][Full Text] [Related]
27. Perfusion bioreactor for small diameter tissue-engineered arteries. Williams C; Wick TM Tissue Eng; 2004; 10(5-6):930-41. PubMed ID: 15265311 [TBL] [Abstract][Full Text] [Related]
28. The bioartificial thyroid: a biotechnological perspective in endocrine organ engineering for transplantation replacement. Toni R; Casa CD; Spaletta G; Marchetti G; Mazzoni P; Bodria M; Ravera S; Dallatana D; Castorina S; Riccioli V; Castorina EG; Antoci S; Campanile E; Raise G; Rossi R; Ugolotti G; Martorella A; Roti E; Sgallari F; Pinchera A Acta Biomed; 2007; 78 Suppl 1():129-55. PubMed ID: 17465331 [TBL] [Abstract][Full Text] [Related]
29. Generation and transplantation of an autologous vascularized bioartificial human tissue. Mertsching H; Schanz J; Steger V; Schandar M; Schenk M; Hansmann J; Dally I; Friedel G; Walles T Transplantation; 2009 Jul; 88(2):203-10. PubMed ID: 19623015 [TBL] [Abstract][Full Text] [Related]
30. Practical aspects of cardiac tissue engineering with electrical stimulation. Cannizzaro C; Tandon N; Figallo E; Park H; Gerecht S; Radisic M; Elvassore N; Vunjak-Novakovic G Methods Mol Med; 2007; 140():291-307. PubMed ID: 18085215 [TBL] [Abstract][Full Text] [Related]
31. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. Maidhof R; Tandon N; Lee EJ; Luo J; Duan Y; Yeager K; Konofagou E; Vunjak-Novakovic G J Tissue Eng Regen Med; 2012 Nov; 6(10):e12-23. PubMed ID: 22170772 [TBL] [Abstract][Full Text] [Related]
32. Design Approaches to Myocardial and Vascular Tissue Engineering. Akintewe OO; Roberts EG; Rim NG; Ferguson MAH; Wong JY Annu Rev Biomed Eng; 2017 Jun; 19():389-414. PubMed ID: 28471698 [TBL] [Abstract][Full Text] [Related]
33. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities. Birla R; Dhawan V; Huang YC; Lytle I; Tiranathanagul K; Brown D Artif Organs; 2008 Sep; 32(9):684-91. PubMed ID: 18684210 [TBL] [Abstract][Full Text] [Related]
34. Medium perfusion enables engineering of compact and contractile cardiac tissue. Radisic M; Yang L; Boublik J; Cohen RJ; Langer R; Freed LE; Vunjak-Novakovic G Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H507-16. PubMed ID: 14551059 [TBL] [Abstract][Full Text] [Related]
35. Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Narita Y; Hata K; Kagami H; Usui A; Ueda M; Ueda Y Tissue Eng; 2004; 10(7-8):1224-33. PubMed ID: 15363178 [TBL] [Abstract][Full Text] [Related]
36. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Barash Y; Dvir T; Tandeitnik P; Ruvinov E; Guterman H; Cohen S Tissue Eng Part C Methods; 2010 Dec; 16(6):1417-26. PubMed ID: 20367291 [TBL] [Abstract][Full Text] [Related]
37. Current challenges and future trends in manufacturing small diameter artificial vascular grafts in bioreactors. Jafarihaghighi F; Ardjmand M; Mirzadeh A; Hassani MS; Parizi SS Cell Tissue Bank; 2020 Sep; 21(3):377-403. PubMed ID: 32415569 [TBL] [Abstract][Full Text] [Related]
38. Controlling the cellular organization of tissue-engineered cardiac constructs. Gonen-Wadmany M; Gepstein L; Seliktar D Ann N Y Acad Sci; 2004 May; 1015():299-311. PubMed ID: 15201169 [TBL] [Abstract][Full Text] [Related]
39. Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. Sarig U; Nguyen EB; Wang Y; Ting S; Bronshtein T; Sarig H; Dahan N; Gvirtz M; Reuveny S; Oh SK; Scheper T; Boey YC; Venkatraman SS; Machluf M Tissue Eng Part A; 2015 May; 21(9-10):1507-19. PubMed ID: 25602926 [TBL] [Abstract][Full Text] [Related]
40. High-density seeding of myocyte cells for cardiac tissue engineering. Radisic M; Euloth M; Yang L; Langer R; Freed LE; Vunjak-Novakovic G Biotechnol Bioeng; 2003 May; 82(4):403-14. PubMed ID: 12632397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]